A Clinical trial to study the effects of two drugs,Nimbadi guggulu and Pathyashadangam Ghanavati in patients with Migraine.

Phase 2/3

Not yet recruiting

Conditions: Migraine, unspecified. Ayurveda Condition: MIGRAINE,

Registration Number: CTRI/2021/06/034009

Lead Sponsor: DR AMRITHA MOHAN

Brief Summary: This is a randomised open label single centre trial comparing the efficacy of Nimbadi guggulu and Padhyadi ghanavati for 30 days in 40 patients with migraineheadache will be conducted in Alvas ayurveda medical college Vidyagiri Moodbidri Dakshina kannada INdia. Primaryoutcome measures will be relief from *Bheda Todavat Shula(* Intensity of pain), Duration of single episode, Frequency of attack,Photophobia, nausea, vomiting in 90 daysÂ·

Â·

Â·

Â·

Detailed Description: Not available

Recruitment & Eligibility

Status: Not Yet Recruiting

Sex: All

Target Recruitment: 40

Inclusion Criteria

Patients aged 16 â€“ 60 years irrespective of gender religion and socioeconomic status will be selected Patients presenting with clinical features of Ardhavabhedaka will be selected.

Exclusion Criteria

Patients having other types of Shirashula apart from Ardhavabhedaka will be excluded.
Patients suffering from secondary headaches like sinusitis, meningitis etc.
will be excluded.
Patients with any other systemic diseases and pregnancy will be excluded.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Bheda Todavat Shula( Intensity of pain)	90 DAYS
Duration of single episode	90 DAYS
Frequency of attack	90 DAYS
Photophobia	90 DAYS
Nausea	90 DAYS
Vomiting	90 DAYS

Secondary Outcome Measures

Name	Time	Method
NOT APLICABLE	NOT APLICABLE

Trial Locations

Locations (1): ALVAS AYURVEDA MEDICAL COLLEGE AND HOSPITAL
🇮🇳
Kannada, KARNATAKA, India
ALVAS AYURVEDA MEDICAL COLLEGE AND HOSPITAL
🇮🇳Kannada, KARNATAKA, India
DR AMRITHA MOHAN
Principal investigator
9567390630
amrithamohan69@gmail.com